Screening for, and management of, possible arrhythmogenic syndromes (channelopathies/ion channel diseases).
about
The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands.Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndromeCascade screening in families with inherited cardiac diseases driven by cardiologists: feasibility and nationwide outcome in long QT syndrome.EHRA research network surveys: 6 years of EP wires activity.Risk of cardiovascular disease in family members of young sudden cardiac death victims.
P2860
Screening for, and management of, possible arrhythmogenic syndromes (channelopathies/ion channel diseases).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Screening for, and management ...... pathies/ion channel diseases).
@en
Screening for, and management ...... pathies/ion channel diseases).
@nl
type
label
Screening for, and management ...... pathies/ion channel diseases).
@en
Screening for, and management ...... pathies/ion channel diseases).
@nl
prefLabel
Screening for, and management ...... pathies/ion channel diseases).
@en
Screening for, and management ...... pathies/ion channel diseases).
@nl
P2860
P356
P1433
P1476
Screening for, and management ...... pathies/ion channel diseases).
@en
P2093
EHRA Scientific Initiative Commitee
Peter Geelen
P2860
P304
P356
10.1093/EUROPACE/EUQ126
P577
2010-05-01T00:00:00Z